Celldex Therapeutics, Inc (NASDAQ:CLDX) Advances Pipeline And Signals Near-Term Momentum Shift
![]() |
Celldex shows pipeline-driven momentum while fundamental metrics and WMDST valuation flag material downside risk; near-term movement will hinge on clinical readouts and liquidity deployment. |










